Lead neurotoxicity in children: Basic mechanisms and clinical correlates

Brain

Volumn 126, Issue 1, 2003, Pages 5-19

  Lidsky, Theodore I ^b   Schneider, Jay S ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Children; Lead poisoning; Neurotoxicity; Toxic mechanisms; Toxic threshold

Indexed keywords

LEAD;

BEHAVIOR; COGNITION; ENVIRONMENTAL EXPOSURE; HEREDITY; HUMAN; LEAD POISONING; NERVE CELL DIFFERENTIATION; NEUROTOXICITY; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW;

APOPTOSIS; BONE AND BONES; BRAIN; CALCIUM SIGNALING; CHILD; CHILD, PRESCHOOL; COGNITION DISORDERS; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEME; HUMANS; INFANT; LEAD; LEAD POISONING, NERVOUS SYSTEM, CHILDHOOD; MATERNAL EXPOSURE; MAXIMUM ALLOWABLE CONCENTRATION; NEUROGLIA; NEUROTRANSMITTER AGENTS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SOCIAL CLASS;

EID: 0037227997     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awg014     Document Type: Review

References (121)

1. Adams RD, Victor M. Principles of neurology, 5th ed. New York: McGraw-Hill; 1993.
2. Anderson AC, Pueschel SM, Linakis JG. Pathophysiology of lead poisoning. In: Pueschel SM, Linakis JG, Anderson AC, editors. Lead poisoning in children. Baltimore (MD): P.H. Brookes; 1996. p. 75-96.
3. Antonio MT, Corpas I, Leret ML. Neurochemical changes in newborn rat's brain after gestational cadmium and lead exposure. Toxicol Lett 1999; 104: 1-9.
4. Audesirk G. Electrophysiology of lead intoxication: effects on voltage sensitive ion channels. [Review]. Neurotoxicology 1993; 14: 137-47.
5. Audesirk G, Audesirk T. The effects of inorganic lead on voltage sensitive calcium channels differ among cell types and among channel subtypes. Neurotoxicology 1993; 14: 259-65.
6. Beal MF, Brouillet E, Jenkins BG, Ferrante RJ, Kowall NW, Miller JM, et al. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 1993; 13: 4181-92.
7. Bellinger DC. Effect modification in epidemiological studies of low-level neurotoxicant exposures and health outcomes. [Review]. Neurotoxicol Teratol 2000; 22: 133-40.
8. Bellinger D, Dietrich KN. Low-level lead exposure and cognitive function in children. [Review]. Pediatr Ann 1994; 23: 600-5.
9. Bellinger DC, Stiles KM, Needleman HL. Low-level lead exposure, intelligence and academic achievement: a long-term follow-up study. Pediatrics 1992; 90: 855-61.
10. Bellinger D, Hu H, Titlebaum L, Needleman HL. Attentional correlates of dentin and bone lead levels in adolescents. Arch Environ Health 1994; 49: 98-105.
11. 2+-ATPase in synaptic plasma membranes and microsomes of rat cerebral cortex and cerebellum. Ecotoxicol Environ Saf 1996; 33: 157-62.
12. Bouton CM, Frelin LP, Forde CE, Godwin HA, Pevsner J. Synaptotagmin I is a molecular target for lead. J Neurochem 2001; 76: 1724-35.
13. Bradbury MW, Deane R. Permeability of the blood-brain barrier to lead. [Review]. Neurotoxicology 1993; 14: 131-6.
14. Bressler JP, Goldstein GW. Mechanisms of lead neurotoxicity. [Review]. Biochem Pharmacol 1991; 41: 479-84.
15. Bressler J, Kim KA, Chakraborti T, Goldstein G. Molecular mechanisms of lead neurotoxicity. [Review]. Neurochem Res 1999; 24: 595-600.
16. Brody DJ, Pirkle JL, Kramer RA, Flegal KM, Matte TD, Gunter EW, et al. Blood levels in the U.S. population. Phase 1 of the Third National Health and Nutrition Examination Survey (NHANES III, 1988 to 1991). JAMA 1994; 272: 277-83.
17. Brown LL, Schneider JS, Lidsky TI. Sensory and cognitive functions of the basal ganglia. [Review]. Curr Opin Neurobiol 1997; 7: 157-63.
18. Bruner AB, Joffe A, Duggan AK, Casella JF, Brandt J. Randomised study of cognitive effects of iron supplementation in non-anaemic iron-deficient adolescent girls. Lancet 1996; 348: 992-6.
19. Cheng Y, Willett WC, Schwartz J, Sparrow D, Weiss S, Hu H. Relation of nutrition to bone lead and blood lead levels in middle-aged to elderly men. The Normative Aging Study. Am J Epidemiol 1998; 147: 1162-74.
20. Chisolm JJ Jr. Medical management. In: Pueschel SM, Linakis JG, Anderson AC, editors. Lead poisoning in childhood. Baltimore (MD): P.H. Brookes; 1996. p. 141-62.
21. Chuang HY, Schwartz J, Gonzales-Cossio T, Lugo MC, Palazuelos E, Aro A, et al. Interrelations of lead levels in bone, venous blood, and umbilical cord blood with exogenous lead exposure through maternal plasma lead in peripartum women. Environ Health Perspect 2001; 109: 527-32.
22. Coria F, Berciano MT, Berciano J, LaFarga M. Axon membrane remodeling in the lead-induced demyelinating neuropathy of the rat. Brain Res 1984; 291: 369-72.
23. Cory-Schlecta DA, Schaumburg HH. Lead, inorganic. In: Spencer PS, Schaumburg HH, Ludolph AC, editors. Experimental and clinical neurotoxicology. 2nd ed. New York: Oxford University Press; 2000. p. 708-20.
24. Crumpton T, Atkins DS, Zawia NH, Barone S Jr. Lead exposure in pheochromocytoma (PC12) cells alters neural differentiation and Spl DNA binding. Neurotoxicology 2001; 22: 49-62.
25. Dabrowska-Bouta B, Sulkowski G, Bartosz G, Walski M, Rafalowska U. Chronic lead intoxication affects the myelin membrane status in the central nervous system of adult rats. J Mol Neurosci 1999; 13: 127-39.
26. Dabrowska-Bouta B, Sulkowski G, Walski M, Struzynska L, Lenkiewicz A, Rafalowska U. Acute lead intoxication in vivo affects myelin membrane morphology and CNPase activity. Exp Toxicol Pathol 2000; 52: 257-63.
27. Deng W, McKinnon RD, Poretz RD. Lead exposure delays the differentiation of oligodendroglial progenitors in vitro. Toxicol Appl Pharmacol 2001; 174: 235-44.
28. Devoto P, Flore G, Ibba A, Fratta W, Pani L. Lead intoxication during intrauterine life and lactation but not during adulthood reduces nucleus accumbens dopamine release as studied by brain microdialysis. Toxicol Lett 2001; 121: 199-206.
29. Dietrich KN, Berger OG, Succop PA, Hammond PB, Bornschein RL. The developmental consequences of low to moderate prenatal and postnatal lead exposure: intellectual attainment in the Cincinnati Lead Study Cohort following school entry. Neurotoxicol Teratol 1993a; 15: 37-44.
30. Dietrich KN, Berger OG, Succop PA. Lead exposure and the motor developmental status of urban six-year-old children in the Cincinnati Prospective Study. Pediatrics 1993b; 91: 301-7.
31. Dietrich KN, Ris MD, Succop PA, Berger OG, Bornschein RL. Early exposure to lead and juvenile delinquency. Neurotoxicol Teratol 2001; 23: 511-8.
32. Dlugos DJ, Moss EM, Duhaime A-C, Brooks-Kayal AR. Language-related cognitive declines after left temporal lobectomy in children. Pediatr Neurol 1999; 21: 444-9.
33. Dyatlov VA, Platoshin AV, Lawrence DA, Carpenter DO. Lead potentiates cytokine- and glutamate-mediated increases in permeability of the blood-brain barrier. Neurotoxicology 1998; 19: 283-91.
34. Dyck PJ, O'Brien PC, Ohnishi A. Lead neuropathy: 2. Random distribution of segmental demyelination among 'old internodes' of myelinated fibers. J Neuropathol Exp Neurol 1977; 36: 570-5.
35. Faust D, Brown J. Moderately elevated blood lead levels: effects on neuropsychologic functioning in children. Pediatrics 1987; 80: 623-9.
36. 2+ ion concentrations in cultured rat hippocampal neurons by a calmodulin-dependent mechanism. Neurotoxicology 2000; 21: 365-78.
37. Fox DA, Cainpbell ML, Blocker YS. Functional alterations and apoptotic cell death in the retina following developmental or adult lead exposure. Neurotoxicology 1997; 18: 645-64.
38. Gardella C. Lead exposure in pregnancy: a review of the literature and argument for routine prenatal screening. [Review]. Obstet Gynecol Survey 2001; 56: 231-8.
39. Gilbert ME, Mack CM, Lasley SM. Chronic developmental lead exposure increases the threshold for long-term potentiation in rat dentate gyrus in vivo. Brain Res 1996; 736: 118-24.
40. Gillis KD, Mossner R, Neher E. Protein kinase C enhances exocytosis from chromaffin cells by increasing the size of the readily releasable pool of secretory granules. Neuron 1996; 16: 1209-20.
41. Grantham-McGregor S, Ani C. A review of studies on the effect of iron deficiency on cognitive development in children. [Review]. J Nutr 2001; 131: 649S-666S.
42. Grobler SR, Theunissen FS, Kotze TJ. The relation between lead concentrations in human dental tissues and in blood. Arch Oral Biol 2000; 45: 607-9.
43. Gulson BL, Pounds JG, Mushak P, Thomas BJ, Gray B, Korsch MJ. Estimation of cumulative lead release (lead flux) from the maternal skeleton during pregnancy and lactation. J Lab Clin Med 1999; 134: 631-40.
44. 2 zinc finger proteins. Mol Pharmacol 1999; 56: 982-8.
45. He L, Poblenz AT, Medrano CJ, Fox DA. Lead and calcium produce rod photoreceptor cell apoptosis by opening the mitochondrial permeability transition pore. J Biol Chem 2000; 275: 12175-84.
46. Hitzfeld B, Taylor DM. Characteristics of lead adaptation in a rat kidney cell line. I. Uptake and subcellular and subnuclear distribution of lead. Mol Toxicol 1989; 2: 151-62.
47. Holdstein Y, Pratt H, Goldsher M, Rosen G, Shenhav R, Linn S, et al. Auditory brainstem evoked potentials in asymptomatic lead-exposed subjects. Laryngol Otol 1986; 100: 1031-46.
48. Holtzman D, Olson JE, DeVries C, Bensch K. Lead toxicity in primary cultured cerebral astrocytes and cerebellar granular neurons. Toxicol Appl Pharmacol 1987; 89: 211-25.
49. Jablonska L, Walski M, Rafalowska U. Lead as an inductor of some morphological and functional changes in synaptosomes from rat brain. Cell Mol Neurobiol 1994; 14: 701-9.
50. Johnson MA. High calcium intake blunts pregnancy-induced increases in maternal blood lead. [Review]. Nutr Rev 2001; 59: 152-6.
51. Kempermann G, Kuhn HG, Gage FH. More hippocampal neurons in adult mice living in an enriched environment. Nature 1997; 386: 493-5.
52. Kern M, Audesirk G. Inorganic lead may inhibit neurite development in cultured rat hippocampal neurons through hyperphosphorylation. Toxicol Appl Pharmacol 1995; 134: 111-23.
53. Kern M, Audesirk G. Stimulatory and inhibitory effects of inorganic lead on calcineurin. Toxicology 2000; 150: 171-8.
54. Kerper LE, Hinkle PM. Lead uptake in brain capillary endothelial cells: activation by calcium store depletion. Toxicol Appl Pharmacol 1997a; 146: 127-33.
55. Kerper LE, Hinkle PM. Cellular uptake of lead is activated by depletion of intracellular calcium stores. J Biol Chem 1997b; 272: 8346-52.
56. Lanphear BP, Dietrich K, Auinger P, Cox C. Cognitive deficits associated with blood lead concentrations <10μg/dl in US children and adolescents. Public Health Rep 2000; 115: 521-9.
57. Lasley SM, Green MC, Gilbert ME. Influence of exposure period on in vivo hippocampal glutamate and GABA release in rats chronically exposed to lead. Neurotoxicology 1999; 20: 619-29.
58. Lasley SM, Green MC, Gilbert ME. Rat hippocampal NMDA receptor binding as a function of chronic lead exposure level. Neurotoxicol Teratol 2001; 23: 185-9.
59. Lawrence DA. In vivo and in vitro effects of lead on humoral and cell-mediated immunity. Infect Immun 1981; 31: 136-9.
60. 2+ entry into cultured astroglia. Toxicol Sci 1998; 46: 90-100.
61. Leggett RW. An age-specific kinetic model of lead metabolism in humans. [Review]. Environ Health Perspect 1993; 101: 598-616.
62. Lezak MD. Neuropsychological assessment. 3rd ed. New York: Oxford University Press; 1995.
63. Li PJ, Sheng YZ, Wang QY, Gu LY, Wang YL. Transfer of lead via placenta and breast milk in human. Biomed Environ Sci 2000; 13: 85-9.
64. Lin-Fu JS. Undue absorption of lead among children - a new look at an old problem. [Review]. New Engl J Med 1972; 286: 702-10.
65. Lin-Fu J. Modern history of lead poisoning: a century of discovery and rediscovery. In: Needleman HL, editor. Human lead exposure. Boca Raton (FL): CRC Press; 1992. p. 23-43.
66. Lindahl LS, Bird L, Legare ME, Mikeska G, Bratton GR, Tiffany-Castiglioni E. Differential ability of astroglia and neuronal cells to accumulate lead: dependence on cell type and on degree of differentiation. Toxicol Sci 1999; 50: 236-43.
67. Lorton D, Anderson WJ. The effects of postnatal lead toxicity on the development of cerebellum in rats. Neurobehav Toxicol Teratol 1986; 8: 51-9.
68. 3H]CNQX) binding in response to chronic low-level lead exposure: reversal versus potentiation by chronic dopamine agonist treatment. J Neurochem 1997; 69: 2466-76.
69. Mendelsohn AL, Dreyer BP, Fierman AH, Rosen CM, Legano LA, Kruger HA, et al. Low-level lead exposure and behavior in early childhood. Pediatrics 1998; 101: E10.
70. Moorhouse SR, Carden S, Drewitt PN, Eley BP, Hargreaves RJ, Pelling D. The effect of chronic low level lead exposure on blood-brain barrier function in the developing rat. Biochem Pharmacol 1988; 37: 4539-47.
71. Nachshen DA. Selectivity of the Ca binding site in the synaptosome Ca channels. Inhibition of Ca influx by multivalent metal cations. J Gen Physiol 1984; 83: 941-67.
72. Needleman HL, Gunnoe C, Leviton A, Reed R, Peresie H, Maher C, et al. Deficits in psychologic and classroom performance of children with elevated dentine lead levels. New Engl J Med 1979; 300: 689-95.
73. Needleman HL, Riess JA, Tobin MJ, Biesecker GE, Greenhouse JB. Bone lead levels and delinquent behavior. JAMA 1996; 275: 363-9.
74. 2+ exposure affects hippocampal protein kinase Cã gene and protein expression in rats. Neurosci Lett 2001; 298: 212-6.
75. Norenberg MD, Martinez-Hernandez A. Fine structural localization of glutamine synthetase in astrocytes in rat brain. Brain Res 1979; 161: 303-10.
76. Onalaja AO, Claudio L. Genetic susceptibility to lead poisoning. [Review]. Environ Health Perspect 2000; 108 Suppl 1: 23-8.
77. Otto DA, Fox DA. Auditory and visual dysfunction following lead exposure. [Review]. Neurotoxicology 1993; 14: 191-208.
78. Patrick GW, Anderson WJ. Dendritic alterations of cerebellar Purkinje neurons in postnatally lead-exposed kittens. Dev Neurosci 2000; 22: 320-8.
79. Pueschel SM, Linakis JG, Anderson AC. Lead poisoning: a historical perspective. In: Pueschel SM, Linakis JG, Anderson AC, editors. Lead poisoning in childhood. Baltimore (MD): P.H. Brookes; 1996. p. 1-13.
80. Rafalowska U, Struzynska L, Dabrowska-Bouta B, Lenkiewicz A. Is lead toxicosis a reflection of altered energy metabolism in brain synaptosomes? [Review]. Acta Neurobiol Exp (Warsz) 1996; 56: 611-7.
81. Rampon C, Jiang CH, Dong H, Tang Y-P, Lockhart DJ, Schultz PG, et al. Effects of environmental enrichment on gene expression in the brain. Proc Natl Acad Sci USA 2000; 97: 12880-4.
82. Reddy GR, Zawia NH. Lead exposure alters Egr-1 DNA-binding in the neonatal rat brain. Int J Dev Neurosci 2000; 18: 791-5.
83. Regunathan S, Sundaresan R. Effects of organic and inorganic lead on synaptosomal uptake, release, and receptor binding of glutamate in young rats. J Neurochem 1985; 44: 1642-6.
84. Roberts JR, Reigart JR, Ebeling M, Hulsey TC. Time required for blood lead levels to decline in nonchelated children. J Toxicol Clin Toxicol 2001; 39: 153-60.
85. Rogan WJ, Dietrich KN, Ware JH, Dockery DW, Salganik M, Radcliffe J, et al. The effect of chelation therapy with succimer on neuropsychological development in children exposed to lead. New Engl J Med 2001; 344: 1421-6.
86. Rothenberg SJ, Poblano A, Schnaas L. Brainstem auditory evoked response at five years and prenatal and postnatal blood lead. Neurotoxicol Teratol 2000; 22: 503-10.
87. Rutter M. Low level lead exposure: sources effects and implications. In: Rutter M, Russell-Jones R, editors. Lead versus health. Chichester (UK): John Wiley; 1983. p. 333-70.
88. Schneider JS, Lee MH, Anderson DW, Zuck L, Lidsky TI. Enriched environment during development is protective against, lead-induced neurotoxicity. Brain Res 2001; 896: 48-55.
89. Schwartz J. Low-level lead exposure and children's IQ: a meta analysis and search for a threshold. Environ Res 1994; 65: 42-55.
90. Schwartz BS, Lee B-K, Lee G-S, Stewart WF, Simon D, Kelsey K, Todd AC. Associations of blood lead, dimercaptosuccinic acid-chelatable lead and tibia lead with polymorphisms in the vitamin D receptor and [delta]-aminolevulinic acid dehydratase genes. Environ Health Perspect 2000a; 108: 949-54.
91. Sciarillo WG, Alexander G, Farrell KP. Lead exposure and child behavior. Am J Public Health 1992; 82: 1356-60.
92. Scortegagna M, Hanbauer I. The effect of lead exposure and serum deprivation on mesencephalic primary cultures. Neurotoxicology 1997; 18: 331-9.
93. Shukla GS, Hussain T, Chandra SV. Possible role of regional superoxide dismutase activity and lipid peroxide levels in cadmium neurotoxicity: in vivo and in vitro studies in growing rats. Life Sci 1987; 41: 2215-21.
94. Sierra EM, Tiffany-Castiglioni E. Reduction of glutamine synthetase activity in astroglia exposed in culture to low levels of inorganic lead. Toxicology 1991; 65: 295-304.
95. Silbergeld EK. Mechanisms of lead neurotoxicity, or looking beyond the lamppost. [Review]. FASEB J 1992; 6: 3201-6.
96. Silbergeld EK, Wolinsky JS, Goldstein GW. Electron probe microanalysis of isolated brain capillaries poisoned with lead. Brain Res 1980; 189: 369-76.
97. Slomianka L, Rungby J, West MJ, Danscher G, Andersen AH. Dose-dependent bimodal effect of low-level lead exposure on the developing hippocampal region of the rat: a volumetric study. Neurotoxicology 1989; 10: 177-90.
98. Stiles KM, Bellinger DC. Neuropsychological correlates of low-level lead exposure in school-age children: a prospective study. Neurotoxicol Teratol 1993; 15: 27-35.
99. Stokes L, Letz R, Gerr F, Kolczak M, McNeil FE, Chettle DR, et al. Neurotoxicity in young adults 20 years after childhood exposure to lead: the Bunker Hill experience. Occup Environ Med 1998; 55: 507-16.
100. Struzynska L, Dabrowska-Bouta B, Rafalowska U. Acute lead toxicity and energy metabolism in rat brain synaptosomes. Acta Neurobiol Exp (Warsz) 1997; 57: 275-81.
101. Sundström R, Müntzing K, Kalimo H, Sourander P. Changes in the integrity of the blood-brain barrier in suckling rats with low dose lead encephalopathy. Acta Neuropathol (Berl) 1985; 68: 1-9.
102. Tang HW, Yan HL, Hu XH, Liang YX, Shen XY. Lead cytotoxicity in primary cultured rat astrocytes and Schwann cells. J Appl Toxicol 1996; 16: 187-96.
103. Tang H-W, Huel G, Campagna D, Hellier G, Boissinot C, Blot P. Neurodevelopmental evaluation of 9-month-old infants exposed to low levels of lead in utero: involvement of monoamine neurotransmitters. J Appl Toxicol 1999; 19: 167-72.
104. Teuber H-L. Neglected aspects of the post-traumatic syndrome. In: Walker AE, Caveness WF, Critchley M, editors. The late effects of head injury. Springfield (IL): C.C. Thomas; 1969. p.
105. Tiffany-Castiglioni E, Sierra EM, Wu J-N, Rowles TK. Lead toxicity in neuroglia. [Review]. Neurotoxicology 1989; 10: 417-43.
106. Tong S, Baghurst P, McMichael A, Sawyer M, Mudge J. Lifetime exposure to environmental lead and children's intelligence at 11-13 years: the Port Pirie cohort study. BMJ 1996; 312: 1569-75.
107. Tong S, von Schirnding YE, Prapamontol T. Environmental lead exposure: a public health problem of global dimensions. [Review]. Bull World Health Organ 2000; 78: 1068-77.
108. Villeda-Hernandez J, Barroso-Moguel R, Méndez-Armenta M, Nava-Ruíz C, Huerta-Romero R, Ríos C. Enhanced brain regional lipid peroxidation in developing rats exposed to low level lead acetate. Brain Res Bull 2001; 55: 247-51.
109. Walkowiak J, Altmann L, Krämer U, Sveinsson K, Turfeld M, Weishoff-Houben M, et al. Cognitive and sensorimotor functions in 6-year-old children in relation to lead and mercury levels: adjustment for intelligence and contrast sensitivity in computerized testing. Neurotoxicol Teratol 1998; 20: 511-21.
110. Wasserman GA, Musabegovic A, Liu X, Kline J, Factor-Litvak P, Graziano JH. Lead exposure and motor functioning in 4 1/2 year-old children: the Yugoslavia prospective study. J Pediatr 2000a; 137: 555-61.
111. Wasserman GA, Liu X, Popovac D, Factor-Litvak P, Kline J, Waternaux C, et al. The Yugoslavia Prospective Lead Study: contributions of prenatal and postnatal lead exposure to early intelligence. Neurotoxicol Teratol 2000b; 22: 811-8.
112. Webb SJ, Monk CS, Nelson CA. Mechanisms of postnatal neurobiological development: implications for human development. Dev Neuropsychol 2001; 19: 147-71.
113. White RF, Diamond R, Proctor S, Morey C, Hu H. Residual cognitive deficits 50 years after lead poisoning during childhood. Br J Ind Med 1993; 50: 613-22.
114. Widzowski DV, Finkelstein JN, Pokora MJ, Cory-Schlecta DA. Time course of postnatal lead-induced changes in dopamine receptors and their relationship to changes in dopamine sensitivity. Neurotoxicology 1994; 15: 853-65.
115. Wilson MA, Johnston MV, Goldstein GW, Blue ME. Neonatal lead exposure impairs development of rodent barrel field cortex. Proc Natl Acad Sci USA 2000; 97: 5540-5.
116. Winneke G, Krämer U. Neuropsychological effects of lead in children: interactions with social background variables. Neuropsychobiology 1984; 11: 195-202.
117. Winneke G, Krämer U. Neurobehavioral aspects of lead neurotoxicity in children. [Review]. Cent Eur J Public Health 1997; 5: 65-9.
118. Winneke G, Brockhaus A, Ewers U, Krämer U, Neuf M. Results from the European Multicenter Study on lead neurotoxicity in children: implications for risk assessment. Neurotoxicol Teratol 1990; 12: 553-9.
119. Zawia NH, Harry GJ. Developmental exposure to lead interferes with glial and neuronal differential gene expression in the rat cerebellum. Toxicol Appl Pharmacol 1996; 138: 43-7.
120. Zawia NH, Sharan R, Brydie M, Oyama T, Crumpton T. Sp1 as a target site for metal-induced perturbations of transcriptional regulation of developmental brain gene expression. Brain Res Dev Brain Res 1998; 107: 291-8.
121. Zheng W, Lu Y-M, Lu G-Y, Zhao Q, Cheung O, Blaner WS. Transthyretin, thyroxine, and retinol-binding protein in human cerebrospinal fluid: effect of lead exposure. Toxicol Sci 2001; 61: 107-14.